06 Nov Presence and maturity levels of tertiary lymphoid structures (TLS) are associated with better outcomes in LS-SCLC
Posted at 16:21h
in INMUNOTHERAPY
ID: 03321
Authors: Núñez-Buiza, Ángel (1,2); Gracia, Jose (1,2); Gómez-Sánchez, David (1,2,3); Panouillot, Marylou (13); Houel, Anna (13); Dieu-Nosjean, Marie-Caroline (13); Conde, Esther (5); Solorzano, Jose Luis (6); Garrido-Martín, Eva María (3,8); Guimarães, Susana (11,12); Nadal, Ernest (9); Molina-Pinelo, Sonia (3,10); Ucero, Álvaro Conrado (1,2,3,4); Paz-Ares, Luis (1,2,3,4,7)
Topic: INMUNOTHERAPY
Read